161Tb-LNC1011

· Peking Union Medical College Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 161Tb-LNC1011, covering 2026-02-02 to 2026-02-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Preliminary Efficacy of 161Tb-LNC1011 (PSMA Radioligand) in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) [EARLY_Phase 1]

See pricing